Amla

What is amla?

Amla (Phyllanthus emblica, also called Emblica officinalis) is a small, sour, pale green fruit that grows across India and Southeast Asia. It is a staple of Ayurvedic tradition, where it is a key ingredient in the herbal mix triphala and the jam-like preparation chyawanprash. Amla is rich in vitamin C, tannins and other polyphenols, which is why it is often marketed as an antioxidant superfood.

What the research says

Most amla research looks at cardiometabolic markers rather than weight. A 2023 meta-analysis of five randomized controlled trials found that amla supplementation was associated with lower C-reactive protein, LDL cholesterol, total cholesterol and triglycerides, and higher HDL cholesterol. Participants were mostly 40 to 58 years old with an average BMI around 25.5, and studies lasted 3 to 12 weeks. The authors described amla as showing promise and said further studies were needed.

Five short trials are a thin evidence base, and the products and doses used varied. The research says little about body weight or fat loss, and claims that amla boosts mitochondrial energy production rely on cell and animal studies rather than human trials.

How it’s used in supplements

Amla is sold as dried fruit powder, juice and standardized extracts. Some trials have used specific patented extracts, so results from those cannot automatically be applied to an unspecified amount of amla inside a blend. In Mitolyn, the amount is not disclosed.

Amla is widely eaten as a food and is generally considered well tolerated. Because studies show effects on blood lipids and, in some cases, blood sugar, people taking cholesterol or diabetes medication should mention it to their doctor. Pregnancy and breastfeeding data for concentrated supplements are limited.

In Ayurvedic practice, amla is usually eaten as a food or taken as part of traditional preparations rather than as a concentrated extract, and its sour, astringent taste is part of why it is often paired with sweeter ingredients. That long food history is reassuring for general tolerability, but it does not tell us how concentrated extracts behave in combination with other botanicals.

Bottom line: amla has a small but encouraging body of randomized trials for cholesterol, triglycerides and CRP, mostly over a few weeks to three months. The evidence for weight loss or for any effect on mitochondria in people is lacking. It may be a sensible part of a heart-healthy approach, but the size and durability of its effects still need confirmation in larger, longer studies.